08.31.26 -- Next-Gen Cell & Gene Manufacturing Solutions

Scaling vector production creates timing constraints and process risks. Discover how advanced transfection strategies enhance batch consistency and streamline commercial scale-up.

Fully automated workflows simplify cell labeling and magnetic separation, delivering reproducible manufacturing for virus- and cancer-targeted therapies.

Explore animal-free hydrolysates and yeast extracts in filtered formats designed to support robust cell culture performance and bioprocess yield.

Digital PCR workflows enable sensitive detection of trace replication-competent lentivirus in complex samples, driving confident decision-making.

Programmable incubators deliver accurate temperature and humidity control, recreating real-world conditions for cell culturing and shelf-life testing.

Learn about innovative cell retention technology that supports continuous bioprocessing through perfusion cell culture for longer run times, higher product yields, and reduced costs. 

Plate-based laboratory units enable compliant, controlled freezing and thawing for single-use bioprocess containers ranging from 1 mL to 10 L.

Secure data integration bridges manufacturing systems and enterprise IT, establishing long-term interoperability across complex facilities.

This contract manufacturing partner delivers end-to-end contract manufacturing solutions for pharmaceutical, diagnostics, and medical device companies.

Modular workflow design balances processing efficiency with therapy performance, helping teams maintain stringent quality standards at scale.

Novel circular DNA formats improve transfection stability and lower cellular toxicity while minimizing immune response during gene editing.

Automated cell expansion systems provide scalable bioreactor connectivity, supporting therapies seamlessly from development to commercial production.

Applying quality-by-design principles to raw material inputs reduces contamination risk and simplifies regulatory compliance during scale-up.